| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | negative regulation of protein localization to microtubule | 5.28e-05 | 5 | 48 | 2 | GO:1902817 | |
| GeneOntologyBiologicalProcess | regulation of protein localization to microtubule | 5.28e-05 | 5 | 48 | 2 | GO:1902816 | |
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 34621053 | ||
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 33731850 | ||
| Pubmed | Germline loss-of-function SAMD9 and SAMD9L alterations in adult myelodysplastic syndromes. | 2.19e-06 | 2 | 52 | 2 | 30322869 | |
| Pubmed | [Pancytopenia in children caused by SAMD9/9L mutation: 5 cases report and literature review]. | 2.19e-06 | 2 | 52 | 2 | 37357006 | |
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 29447249 | ||
| Pubmed | SAMD9 and SAMD9L in inherited predisposition to ataxia, pancytopenia, and myeloid malignancies. | 2.19e-06 | 2 | 52 | 2 | 29535429 | |
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 17407603 | ||
| Pubmed | Viral host range factors antagonize pathogenic SAMD9 and SAMD9L variants. | 2.19e-06 | 2 | 52 | 2 | 36894052 | |
| Pubmed | PARP14 correlates with GBM proliferation and poor prognosis by elevating expression of SAMD/SAMD9L. | 6.57e-06 | 3 | 52 | 2 | 37612499 | |
| Pubmed | 6.57e-06 | 3 | 52 | 2 | 33038986 | ||
| Pubmed | 6.57e-06 | 3 | 52 | 2 | 37922358 | ||
| Pubmed | 6.57e-06 | 3 | 52 | 2 | 32770553 | ||
| Pubmed | 1.69e-05 | 102 | 52 | 4 | 9734811 | ||
| Pubmed | Assay and properties of rab6 interaction with dynein-dynactin complexes. | 4.58e-05 | 7 | 52 | 2 | 16473624 | |
| Pubmed | 6.10e-05 | 8 | 52 | 2 | 19557197 | ||
| Pubmed | 6.97e-05 | 686 | 52 | 7 | 29987050 | ||
| Pubmed | 1.52e-04 | 339 | 52 | 5 | 37232246 | ||
| Pubmed | 3.30e-04 | 18 | 52 | 2 | 31791063 | ||
| Pubmed | 7.51e-04 | 27 | 52 | 2 | 23740937 | ||
| Pubmed | 8.08e-04 | 28 | 52 | 2 | 34963058 | ||
| Interaction | NUP210L interactions | 1.11e-07 | 5 | 46 | 3 | int:NUP210L | |
| Cytoband | 7q21.2 | 1.31e-04 | 15 | 52 | 2 | 7q21.2 | |
| Cytoband | 22q12.3 | 6.50e-04 | 33 | 52 | 2 | 22q12.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr15q25 | 8.10e-04 | 160 | 52 | 3 | chr15q25 | |
| Cytoband | 10p13 | 1.10e-03 | 43 | 52 | 2 | 10p13 | |
| GeneFamily | Guanylate cyclase receptors|DENN/MADD domain containing | 1.06e-03 | 25 | 35 | 2 | 504 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 1.18e-02 | 718 | 35 | 5 | 28 | |
| GeneFamily | Sterile alpha motif domain containing | 1.26e-02 | 88 | 35 | 2 | 760 | |
| ToppCell | Enterocyte-C_05|Enterocyte / shred on cell type and cluster | 3.28e-06 | 196 | 52 | 5 | c307e5a70186567c62da938caa21749dc0e929d0 | |
| ToppCell | critical|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.53e-06 | 199 | 52 | 5 | 16c55cb8a0e740342009965f0eddfb0ed2858fab | |
| ToppCell | PBMC-Mild-cDC_2|Mild / Compartment, Disease Groups and Clusters | 1.88e-05 | 135 | 52 | 4 | cb9d834f8301cf53f20e09c3f4cb6a148690196a | |
| ToppCell | 368C-Fibroblasts-Fibroblast-H-|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.99e-05 | 152 | 52 | 4 | dbfb4d4de36ef9f5c7da1950baa915b12788685e | |
| ToppCell | 368C-Fibroblasts-Fibroblast-H|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.99e-05 | 152 | 52 | 4 | 9f3682da00fd627e80aa820ecc6f5fed23b9738a | |
| ToppCell | 368C-Fibroblasts-Fibroblast-H-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 3.14e-05 | 154 | 52 | 4 | 66065c0763c83d98084ca6969694c3af37e43274 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-H|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 3.14e-05 | 154 | 52 | 4 | f29316d4b4dcdb23bd427d78068e65a9802f7f07 | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Tubular-6|TCGA-Stomach / Sample_Type by Project: Shred V9 | 3.56e-05 | 159 | 52 | 4 | 655c0749c238bd68cb797adb83e25a23b8a3cc9d | |
| ToppCell | ASK428-Epithelial-Transformed_epithelium|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 6.98e-05 | 189 | 52 | 4 | 87189275234b5d59484c58acbb14a09903f2b578 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_NK-natural_killer_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 7.72e-05 | 194 | 52 | 4 | 0abca32c3547a45cebab0bd69c1f7a0002deaa80 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_NK-natural_killer_cell|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 7.72e-05 | 194 | 52 | 4 | a3a81638b55cb5fc08fe83c8b88f68d49b87e6cb | |
| ToppCell | ASK428-Epithelial-Transformed_epithelium|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 7.87e-05 | 195 | 52 | 4 | c750602c765a51075ba6ede78e3ba80b62374481 | |
| ToppCell | COVID-19_Severe-NK_activated|World / disease group, cell group and cell class | 8.19e-05 | 197 | 52 | 4 | a60db36d1a192998e3ded63e0c7c08d41689f95f | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_activated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.35e-05 | 198 | 52 | 4 | ce92d5fbc2eac27fb246b044fb1914ab92506275 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_activated|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.35e-05 | 198 | 52 | 4 | fed823d6e684d113bcc9ff3cd1803bb001aa02fa | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_activated|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.35e-05 | 198 | 52 | 4 | 0e918e9db9b884f5328d438e90efe065e27266ee | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_activated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 8.35e-05 | 198 | 52 | 4 | 1ef3a6bd681c223eed58300348adfef89df5563c | |
| ToppCell | severe|World / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 8.51e-05 | 199 | 52 | 4 | c24aacef7405700bc5d0b736a38feea12b7f17c8 | |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK-NK_activated|COVID-19_Severe / Disease group, lineage and cell class | 8.51e-05 | 199 | 52 | 4 | edf5f80b4c299e6bf462675f2cd3329d86c923d8 | |
| ToppCell | COVID-19_Severe-NK_activated|COVID-19_Severe / disease group, cell group and cell class | 8.51e-05 | 199 | 52 | 4 | bda28d975f4017ec5bded1d3c72310eabc5aac07 | |
| ToppCell | mild-NK|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 8.68e-05 | 200 | 52 | 4 | a11fb1d7e124c352eb73fea0e0ec0fed577c97f7 | |
| ToppCell | COVID-19_Severe-NK_activated|COVID-19_Severe / Disease condition and Cell class | 8.68e-05 | 200 | 52 | 4 | f1f6c7f7f75f891c9ccf6bf58f4d65b9cf10bbd8 | |
| Disease | Familial monosomy 7 syndrome | 2.81e-06 | 2 | 50 | 2 | cv:C5681220 | |
| Disease | octanoylcarnitine measurement | 1.01e-04 | 9 | 50 | 2 | EFO_0021042 | |
| Disease | systemic scleroderma, systemic lupus erythematosus | 8.91e-04 | 26 | 50 | 2 | EFO_0000717, MONDO_0007915 | |
| Disease | physical activity measurement, body mass index | 9.64e-04 | 114 | 50 | 3 | EFO_0004340, EFO_0008002 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TFFLNGMQVNRLSSC | 351 | Q5RHP9 | |
| GIRNSFTMEATFCGS | 526 | Q8NEM8 | |
| SRGCAFVTFSTRAMA | 171 | O95319 | |
| LRCMQVGGNASASSF | 76 | Q9NP61 | |
| ATFSSLRAMFATRCD | 741 | Q8TD16 | |
| RDSCTDNSMQFGTRT | 71 | Q6ZN30 | |
| SQFGRSVFDIGFCMS | 151 | Q7Z5W3 | |
| AFFASHQCSNRIGSM | 121 | Q9NWN3 | |
| SAQFRRASFMGSTFN | 351 | O76090 | |
| SGCLGDTQFSFRMRQ | 86 | Q8NEG7 | |
| DTQFSFRMRQCGGQR | 91 | Q8NEG7 | |
| RQSMNNFQGLRSFGC | 96 | P35318 | |
| RKFSCMFFGAVSSDQ | 371 | Q6WBX8 | |
| RRRNSTSSTNQNMFC | 1526 | O75140 | |
| IMRQTNRFFFCGHTS | 201 | Q504Q3 | |
| LFASLGMVAASFCRS | 96 | O15427 | |
| RGLRSFMSANTFGNA | 276 | Q5U4P2 | |
| LECMFARTRSTSANG | 416 | Q8IYD8 | |
| MTGIAAASFFSNTCR | 1 | Q86VZ6 | |
| TGMCSRVNSNFRFSK | 136 | Q9UKX5 | |
| MGNSRSRVGRSFCSQ | 1 | Q6P9B6 | |
| TGMTFRLSFCGSNRI | 166 | Q8NGF4 | |
| MARECGAGTFVNFAS | 851 | Q16827 | |
| QMRSSGSKRNAFATC | 226 | Q8NHA4 | |
| NEGRFCRSSSMADRS | 11 | O95816 | |
| CRAECMQSSRFTNFV | 436 | Q96SD1 | |
| GMGFSTRVTNRNRQC | 221 | P48745 | |
| EMGFSRVLCFTNSRE | 501 | Q8N8A6 | |
| VFSARMGSFCGSTNN | 171 | Q9P278 | |
| TGFSCDGTANTFRVM | 396 | Q9H0C5 | |
| SSFASCLRGNIVMVF | 421 | Q92819 | |
| QAMEFCQRVGSRATT | 631 | Q96GR2 | |
| FSRTARDNRLGCMFV | 111 | Q6PCB6 | |
| MSYNCCSRNFSSRSF | 1 | Q3LI77 | |
| TQAMSTRSNCGSRSF | 106 | P0C7U9 | |
| SSGFQRMSVINFECN | 421 | P11717 | |
| VFRFASACMNSRTNG | 221 | Q8IVG5 | |
| SNEVFRFASACMNSR | 216 | Q5K651 | |
| RFASACMNSRTNGTI | 221 | Q5K651 | |
| DCRVAQNGGFFRMNS | 131 | Q9UK23 | |
| FSSARGFFIQMTTDC | 531 | O15457 | |
| MRESFIQGCTVRNSF | 2226 | P08F94 | |
| VAFVDMLRNCGSFTR | 1031 | P53396 | |
| RVTFFDETRMASCGQ | 511 | Q96KV7 | |
| SCFGIRRQNSVNSGM | 1201 | Q6ZVD8 | |
| FFTGRGRSCMIVNVN | 471 | O95235 | |
| MQTDTSNLSARSCRF | 1 | P0C7P2 | |
| AMFFRRCSEDASGSA | 11 | Q8TAQ9 | |
| FRSNGGRDMFLSSCT | 146 | Q9Y2P7 | |
| MLDFGLARQFTNSCG | 161 | Q6IQ55 | |
| AGLRCSEFRMVNGSS | 321 | Q4G0T1 | |
| GRFSGRQFSNSRSEM | 81 | A0A578 | |
| CEQCRMAFNGFASFT | 226 | Q68EA5 | |
| SRNRDSVMTLQSGCF | 41 | Q16600 |